New drug trial offers hope for Tough-to-Treat neuroendocrine cancers
NCT ID NCT07080242
Summary
This early-stage study is testing a new drug called BL-M14D1 in 120 patients with advanced small cell lung cancer and other neuroendocrine cancers that have spread and stopped responding to standard treatments. The main goals are to find the safest dose and see how the body processes the drug, while also checking if it helps shrink tumors. This is the first time this experimental treatment is being given to people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emory Winship
RECRUITINGAtlanta, Georgia, 30322, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Icahn School of Medicine at Mount Sinai
NOT_YET_RECRUITINGNew York, New York, 10029, United States
Contact
-
John Theurer Cancer Center-Hackensack
RECRUITINGHackensack, New Jersey, 07601, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
NEXT Dallas
NOT_YET_RECRUITINGDallas, Texas, 75039, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
NEXT Houston
NOT_YET_RECRUITINGHouston, Texas, 77054, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
NEXT Oncology Virginia
RECRUITINGFairfax, Virginia, 22031, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ohio State University
NOT_YET_RECRUITINGColumbus, Ohio, 43201, United States
Contact
-
Prisma Health Cancer Institute
NOT_YET_RECRUITINGGreenville, South Carolina, 29605, United States
Contact
-
Providence Cancer Institute
NOT_YET_RECRUITINGPortland, Oregon, 97213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Rutgers Cancer Institute
NOT_YET_RECRUITINGNew Brunswick, New Jersey, 08901, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
START Dallas- Fort Worth
NOT_YET_RECRUITINGDallas, Texas, 76104, United States
Contact
-
START- San Antonio
NOT_YET_RECRUITINGSan Antonio, Texas, 78229, United States
Contact
-
UCLA
NOT_YET_RECRUITINGLos Angeles, California, 90095, United States
Contact
-
UCSF- San Francisco (Helen Diller Family Comprehensive Cancer Center)
NOT_YET_RECRUITINGSan Francisco, California, 94158, United States
Contact
-
University of Colorado - Anschutz Cancer Pavilion
NOT_YET_RECRUITINGAurora, Colorado, 80045, United States
Contact Email: •••••@•••••
Contact
-
University of Kentucky - Markey Cancer Center
NOT_YET_RECRUITINGLexington, Kentucky, 40536, United States
Contact
-
University of Washington/Fred Hutchinson Cancer Center
NOT_YET_RECRUITINGSeattle, Washington, 98195, United States
Contact
-
Valkyrie Clinical Trials
RECRUITINGLos Angeles, California, 90067, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Yale Cancer Center
NOT_YET_RECRUITINGNew Haven, Connecticut, 06520-8028, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.